Metabolic Health
Common Medications May Block Vitamin B1 Absorption in Small Clinical Trial
UCSF study reveals how metformin and trimethoprim interfere with thiamine uptake, potentially affecting energy metabolism.
Clinical Trial
Mar 29, 2026 2
Results for "Berberine" in Diabetes
20 articles
Metabolic Health
Metformin Shows Promise for Healthy Aging in Non-Diabetic Adults
Wake Forest study explores whether the diabetes drug metformin can trigger cellular changes linked to longevity in healthy people.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
Triple Therapy Targets Diabetes and Muscle Loss in Elderly Adults
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
EDP-305 Targets NASH in Phase 2 Trial Testing Two Doses Against Placebo
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
Clinical Trial
Jun 18, 2026 0
Metabolic Health
Metformin Shows Promise for Improving Blood Vessel Health in Metabolic Syndrome
Four-year study examined whether metformin could protect blood vessels in people with metabolic syndrome beyond its diabetes benefits.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
Thorne's Quercetin Phytosome Trial for Metabolic Health Was Terminated Early
A sponsored 90-day trial of enhanced-absorption quercetin targeting cholesterol, blood sugar, and metabolic age was terminated before completion.
Clinical Trial
Jun 24, 2026 0
Metabolic Health
Metformin Shows Promise for Protecting Memory in Early Cognitive Decline
Columbia University tested whether the diabetes drug metformin could slow memory loss in people with mild cognitive impairment.
Clinical Trial
Mar 29, 2026 1
Metabolic Health
New Drug GFT505 Shows Promise for Fatty Liver Disease in Phase IIb Trial
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
Clinical Trial
Mar 28, 2026 2
Metabolic Health
Nutritional Intervention Shows Promise for Type 2 Diabetes Management
84-person study reveals how targeted nutrition counseling impacts blood sugar, weight, and heart health in diabetic patients.
Clinical Trial
Mar 28, 2026 0
Metabolic Health
RNA Drug Targets ANGPTL3 to Slash Triglycerides in Rare Fat Disorder
A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.
Clinical Trial
Jun 23, 2026 0
Metabolic Health
Metformin Shows Promise for Preventing Frailty in Older Adults
Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
Diabetes Drug Pioglitazone Shows Promise for Reversing Fatty Liver Disease
176-person trial tested whether pioglitazone could improve liver health by targeting insulin resistance in patients with fatty liver disease.
Clinical Trial
Mar 29, 2026 2
Metabolic Health
Metformin May Help or Harm Aging Based on Your Insulin Sensitivity
New study reveals metformin's anti-aging effects depend entirely on whether you're insulin resistant or sensitive.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
12 Weeks of Aerobic Exercise May Tame RAGE-Driven Inflammation in Type 2 Diabetes
A completed University of Michigan trial explored how aerobic exercise training alters RAGE-mediated inflammatory pathways in type 2 diabetic adults.
Clinical Trial
Jun 4, 2026 0
Metabolic Health
Whole Fruit Diet Shows Promise for Reversing Type 2 Diabetes in Clinical Trial
12-week controlled feeding study tests whether eating more whole fruit can improve blood sugar control and potentially reverse diabetes.
Clinical Trial
Mar 29, 2026 1
Metabolic Health
NAD Precursor Combo Tested to Boost Muscle Mitochondria in Elderly Adults
Maastricht University investigated whether NA, NAM, and tryptophan together could restore mitochondrial function in physically compromised older adults.
Clinical Trial
May 8, 2026 0
Metabolic Health
CT-868 Dual Agonist Targets Blood Sugar and Obesity in Phase 2 Diabetes Trial
Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.
Clinical Trial
Jun 16, 2026 0
Metabolic Health
PCSK9 Inhibitor Alirocumab Outperforms Usual Care in Diabetic Mixed Dyslipidemia
Phase 4 trial tests whether alirocumab can better control non-HDL cholesterol in high-risk type 2 diabetics failing statin therapy.
Clinical Trial
Jun 16, 2026 0
Metabolic Health
Metformin Shows Promise for Boosting Vaccine Response in Older Adults
Small trial tested whether the diabetes drug metformin could enhance immune response to pneumonia vaccine in aging adults.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
Mediterranean Diet Plus Intermittent Fasting Shows Promise for Reversing Type 2 Diabetes
Small study tests whether combining Mediterranean eating, intermittent fasting, and exercise can reverse diabetes in 6 months.
Clinical Trial
Mar 28, 2026 2
Page 1 of 2Next